Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC ↑	Name	B/G	Ingredients	Dosage	Form	Price
A02BA03	FAMODAR 20	G	Famotidine - 20mg	20mg	Tablet, film coated	552,319 L.L
A02BA03	FAMONOR	G	Famotidine - 20mg	20mg	Tablet, film coated	220,390 L.L
A02BA03	FAMODAR 40	G	Famotidine - 40mg	40mg	Tablet, film coated	552,319 L.L
A02BA03	FAMONOR	G	Famotidine - 40mg	40mg	Tablet, film coated	439,436 L.L
A03CA02	FLUDINIUM	G	Clidinium bromide - 2.5mg, Trifluoperazine HCl - 1mg		Capsule	386,515 L.L
A03FA03	FARCOTILIUM	G	Domperidone - 10mg	10mg	Capsule, soft gelatin	146,479 L.L
A03FA03	FARCOTILIUM	G	Domperidone - 5mg/5ml	5mg/5ml	Suspension	115,570 L.L
A06AD15	FORLAX POUDRE POUR SOLUTION BUVABLE	B	Macrogol 4000 - 10g	10g	Powder for solution	450,187 L.L
A06AD65	FORTRANS POUDRE POUR SOLUTION BUVABLE	B	Potassium chloride - 0.750g, Sodium chloride - 1460g, Sodium bicarbonate - 1680g, Sodium sulfate anhydrous - 5700g, Macrogol 4000 - 64.000g		Powder for solution	1,136,891 L.L
A07AX03	FUROXYL	G	Nifuroxazide - 200mg	200mg	Capsule	366,037 L.L
A10BD20	FLORIMET 12.5/1000	G	Metformin - 1000mg, Empagliflozin - 12.5mg		Tablet, film coated	1,836,585 L.L
A10BD20	FLORIMET 5/1000	G	Metformin - 1000mg, Empagliflozin - 5mg		Tablet, film coated	1,836,585 L.L
A10BK01	FORXIGA	B	Dapagliflozin - 10mg	10mg	Tablet, film coated	2,927,964 L.L
A10BK03	FLORIANCE 25	G	Empagliflozin - 25mg	25mg	Tablet, film coated	1,791,790 L.L
A10BK03	FLORIANCE 10	G	Empagliflozin - 10mg	10mg	Tablet, film coated	1,791,790 L.L
A16AB04	FABRAZYME	BioTech	Agalsidase beta - 35mg	35mg	Injectable powder for concentrate for solution	L.L
A16AB04	FABRAZYME	BioTech	Agalsidase beta - 35mg	35mg	Injectable powder for concentrate for solution	295,038,213 L.L
B02BB01	FIBRYGA	BioHuman	Fibrinogen, human - 1g	1g	Injectable powder for solution+solvent	40,915,563 L.L
B02BD03	FEIBA	BioHuman	Factor VIII Inhibitor bypassing fraction - 500IU	500U (50U/ml)	Injectable powder for solution+solvent	40,480,699 L.L
B02BD03	FEIBA	BioHuman	Factor VIII Inhibitor bypassing fraction - 1000IU	1000U (50U/ml)	Injectable powder for solution+solvent	79,869,612 L.L
B03AA02	FERRATE	G	Ferrous fumarate - 20mg/ml (iron element)	20mg/ml	Suspension	667,890 L.L
B03AA02	FEOSTA	G	Ferrous fumarate - 200mg	200mg	Tablet, film coated	682,160 L.L
B03AA02	FEOSTA	G	Ferrous fumarate - 200mg	200mg	Tablet, film coated	9,355,300 L.L
B03AB09	FERPLEX	B	Iron trivalent (ferric proteinsuccinylate) - 800mg	800mg	Solution	1,202,739 L.L
B03AC	FER PANPHARMA	G	Iron (sucrose) - 100mg/5ml	100mg/5ml	Injectable solution	2,315,441 L.L
B03AC	FER PANPHARMA	G	Iron (sucrose) - 100mg/5ml	100mg/5ml	Injectable solution	2,315,441 L.L
B03AC	FEROMAX	G	Iron trivalent (hydroxide sucrose complex) - 100mg/5ml	100mg/5ml	Injectable solution	2,213,309 L.L
B03AC	FERRASIL	G	Iron (sucrose) - 100mg/5ml	100mg/5ml	Injectable solution	2,194,047 L.L
B03AC	FERINJECT	B	Iron trivalent (ferric carboxymaltose) - 500mg/10ml	500mg/10ml	Injectable solution	10,212,033 L.L
B03AC	FERAPPLIC	G	Iron trivalent (ferric carboxymaltose) - 500mg/10ml	500mg/10ml	Injectable dispersion	34,231,559 L.L